Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2020 · 10-Q
Revenue$34.00K$34.00K−82.5% vs Q3 2019 Net Income-$3.85M-$3.85MN/M vs Q3 2019 EPS Diluted-$0.30-$0.30N/M vs Q3 2019 Operating Income-$3,848,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$3,627,000N/M Margins · derivedOperating margin-11317.6%−9654.2 pt vs Q3 2019
Net margin-11317.6%−9363.0 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 10, 2020 · 41 d after period end